PCVX · NASDAQ · Biotechnology

Vaxcyte

Developer of high-valency bacterial vaccine candidates using cell-free protein synthesis.

$59.50
After-hours close−0.31 (−0.52%)
At close$59.81(−2.20%)

Breakdown13F · Form 4

Institutions 122.27%Insiders 0.79%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 144.40M · Float 132.08M · 91.5% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
FMR LLC20.85M14.44%13FAug 13, 2026
Jupiter Topco LLC17.97M12.44%13FAug 14, 2026
Janus Henderson Group PLC16.58M11.50%13GMay 15, 2026
T. Rowe Price Investment Management, Inc.12.21M8.45%13FAug 14, 2026
BlackRock, Inc.12.07M8.36%13FAug 7, 2026

Institutions13F, as of Jun 30, 2026

350 holders · 176.56M shares · 51 new positions · 186 increased · 98 reduced · 56 closed

HolderShares% outstandingChg q/qFiled
FMR LLC20.85M14.44%+4.36MAug 13, 2026
Jupiter Topco LLC17.97M12.44%+17.97MnewAug 14, 2026
T. Rowe Price Investment Management, Inc.12.21M8.45%+81.4KAug 14, 2026
BlackRock, Inc.12.07M8.36%+1.10MAug 7, 2026
Ra Capital Management, L.P.11.47M7.95%0Aug 14, 2026
Wellington Management Group LLP7.00M4.85%+1.39MAug 14, 2026
Vanguard Portfolio Management LLC6.59M4.57%+314.0KAug 13, 2026
Vanguard Capital Management LLC6.35M4.40%+82.0KAug 13, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Janus Henderson Group PLC11.50%16.58M13GMay 15, 2026
FMR LLC11.40%16.45M13GMay 6, 2026
RA Capital Management, L.P.8.90%12.97M13GMay 15, 2026
T. Rowe Price Investment Management, Inc.8.60%11.30M13GFeb 17, 2026
BlackRock, Inc.7.60%9.83M13GApr 17, 2025
Vanguard Capital Management5.03%7.25M13GApr 30, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Grant Pickeringdirector, officer: CHIEF EXECUTIVE OFFICER586.5K0.41%Jul 28, 2026
Andrew Guggenhimeofficer: PRESIDENT AND CFO167.0K0.12%Aug 5, 2026
Jim Wassilofficer: CHIEF OPERATING OFFICER157.5K0.11%Aug 5, 2026
Harpreet S. Dhaliwalofficer: Chief Technical Ops Officer76.8K0.05%Aug 5, 2026
Mikhail Eydelmanofficer: SVP, GEN COUNSEL & CORP SEC41.6K0.03%Mar 7, 2025
Elvia Cowanofficer: SVP, Finance & CAO29.0K0.02%Apr 8, 2026
Heath Lukatchdirector19.5K0.01%Jun 16, 2026
Anne S. Drapeaudirector12.5K0.01%Jun 16, 2026
Halley E. Gilbertdirector12.5K0.01%Jun 16, 2026
Teri Loxamdirector12.5K0.01%Jun 16, 2026

2 ten-percent owners hold 10.08M shares by Form 4, outside the officers-and-directors figure above · 10 people have not refiled in the last 18 months (5.70M shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 3, 2026
Andrew Guggenhimeofficer: PRESIDENT AND CFO
Sale · 2 lots10,000$53.89105,176
Aug 3, 2026
Jim Wassilofficer: CHIEF OPERATING OFFICER
Sale · 2 lots2,250$53.86157,541
Aug 5, 2026
Harpreet S. Dhaliwalofficer: Chief Technical Ops Officer
Sale17,000$55.0076,756
Jul 27, 2026
Grant Pickeringdirector, officer: CHIEF EXECUTIVE OFFICER
Sale · 6 lots18,198$55.63586,462
Jul 1, 2026
Jim Wassilofficer: CHIEF OPERATING OFFICER
Sale · 3 lots2,250$56.33156,760
Jul 6, 2026
Andrew Guggenhimeofficer: PRESIDENT AND CFO
Sale · 2 lots10,000$57.28104,395
Jun 26, 2026
Grant Pickeringdirector, officer: CHIEF EXECUTIVE OFFICER
Sale · 9 lots24,237$55.22586,681
Jun 18, 2026
Andrew Guggenhimeofficer: PRESIDENT AND CFO
Sale10,000$53.00104,395
Jun 18, 2026
Grant Pickeringdirector, officer: CHIEF EXECUTIVE OFFICER
Sale · 3 lots23,461$52.50609,918
May 1, 2026
Jim Wassilofficer: CHIEF OPERATING OFFICER
Sale2,250$56.83160,744

CongressHouse and Senate disclosures

MemberTypeAmountOwnerTradedDisclosed
Rep. Gilbert Cisneros · CA31Purchase$1,001 – $15,000May 13, 2026Jun 9, 2026
Rep. Gilbert Cisneros · CA31Purchase$1,001 – $15,000May 12, 2026Jun 9, 2026